Who is the author of 'Bad Blood'?

The author of 'Bad Blood' is John Carreyrou.

What are the main themes in 'Bad Blood'?

The main themes in 'Bad Blood' include True Crime, Business and Economics, Social Commentary, Non-Fiction, Investigative Reporting.

What genre is 'Bad Blood'?

'Bad Blood' is categorized as Non-Fiction, Business and Economics.

What is the main subject of the book 'Bad Blood'?

The main subject of 'Bad Blood' by John Carreyrou is the rise and fall of Theranos, a health technology company founded by Elizabeth Holmes. The book details the company's promise to revolutionize blood testing through innovative technology, the deception surrounding its capabilities, and the subsequent investigation that exposed its fraudulent practices.

Who is the author of 'Bad Blood' and what is his background?

The author of 'Bad Blood' is John Carreyrou. He is a journalist and investigative reporter, known for his work with The Wall Street Journal. Carreyrou has a background in both journalism and science, having graduated from Duke University with a degree in History and a master's degree in Journalism from Columbia University. He gained prominence for uncovering the fraud surrounding the biotech company Theranos and its founder Elizabeth Holmes.

What major themes are explored in 'Bad Blood'?

'Bad Blood' by John Carreyrou explores several major themes, including: Deception and Fraud: The book delves into the lengths to which individuals and companies will go to deceive others for personal gain, highlighting the culture of fraud in Silicon Valley. Ethics in Business: It raises questions about the ethical responsibilities of entrepreneurs and the consequences of prioritizing success over integrity. Ambition and Risk: The story illustrates how ambition can drive innovation but also lead to reckless decisions that affect countless lives. The Role of the Media: Carreyrou explores the impact of investigative journalism in uncovering truth and holding powerful figures accountable. Health and Technology: The implications of technological advancements in healthcare, particularly the risks associated with unproven products and the quest for quick fixes in the medical field, are central to the narrative.

Can you summarize the key events that led to the downfall of Theranos?

The key events that led to the downfall of Theranos, as detailed in 'Bad Blood' by John Carreyrou, include: Founding and Vision: Elizabeth Holmes founded Theranos in 2003 with the vision of revolutionizing blood testing using just a few drops of blood. Initial Funding and Hype: The company attracted significant attention and investment from prestigious venture capitalists and made bold claims about its technology's capabilities, promising results that could rival traditional lab testing. Technical Failures: Despite claims, the technology behind its blood tests remained unproven and unreliable. Internal documents and employee testimonies revealed that the tests often produced inaccurate results. Regulatory Scrutiny: The company's practices came under scrutiny from regulators. In 2015, the Centers for Medicare and Medicaid Services (CMS) began investigating Theranos after a series of Wall Street Journal articles raised questions about the accuracy of their tests. Whistleblowing: Former employees, including whistleblower Tyler Shultz, disclosed serious concerns about the technology and the company's practices, which contributed to an alarming narrative that attracted further media attention. Legal Issues: Theranos faced lawsuits from investors and faced criminal charges against Holmes and former COO Ramesh "Sunny" Balwani for fraud, alleging they misled investors and patients about the company’s technology and finances. Disintegration of Trust: Continuous revelations of deceit, coupled with regulatory actions and legal battles, led to a loss of trust from investors, partners, and the public. Closure and Legal Consequences: Ultimately, Theranos dissolved in 2018, with Holmes and Balwani facing criminal trials for fraud. These events illustrate not only the ambitious vision of Theranos and its founder but also the pitfalls of unchecked innovation in the health technology sector.

How does the author investigate the role of ethics in the biotech industry in 'Bad Blood'?

In 'Bad Blood,' John Carreyrou investigates the role of ethics in the biotech industry by exposing the rampant dishonesty and lack of integrity within Theranos, a health technology company. He highlights how Elizabeth Holmes, the founder, prioritized ambition over ethical considerations, leading to deceit in reporting the capabilities of their blood-testing technology. Through interviews with whistleblowers, former employees, and legal documents, Carreyrou illustrates the consequences of unethical behavior in pursuit of profit, including endangering patient health and misleading investors. The author emphasizes the need for stringent ethical standards in biotech to protect stakeholders and maintain public trust.

Bad Blood Summary | Listen to Podcast-Style Book Summaries on Tales.so

Bad Blood

In "Bad Blood," investigative journalist John Carreyrou unveils the shocking rise and scandalous fall of Theranos, a biotech startup promising revolutionary blood-testing technology. Through a gripping narrative, he exposes the cunning deception of founder Elizabeth Holmes, who captivated investors and the public while hiding the truth about her company's capabilities. As whistleblowers emerge and the medical world takes notice, the web of lies begins to unravel, revealing the dark side of Silicon Valley ambition. With each revelation, the stakes escalate, putting patients' lives at risk and sparking a fierce battle for accountability. This true story of ambition, ethics, and betrayal raises a haunting question: how far will one go to achieve success?

By John Carreyrou

Published: 2020

"Good people are the key to building a great company."

NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close. “Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.

John Carreyrou is an acclaimed American investigative journalist and author, best known for his groundbreaking reporting on the Theranos scandal. A former reporter for The Wall Street Journal, his work has earned him multiple awards, including the George Polk Award for Financial Reporting. Carreyrou's critically praised book, "Bad Blood: Secrets and Lies in a Silicon Valley Startup," details the rise and fall of Theranos and its founder, Elizabeth Holmes. His investigative prowess and commitment to uncovering the truth have made him a prominent figure in journalism. Outside of his writing, Carreyrou frequently speaks on issues of ethics, innovation, and the responsibility of the media in holding powerful entities accountable.

Similar books you might like →